Liquid Biopsy Predicts Immunotherapy Response in Breast Cancer, Study Shows
Researchers at Vanderbilt-Ingram Cancer Center report that RNA sequencing of blood samples can predict immunotherapy response in high-risk breast cancer patients.
Tag: clinical trials
All
Latest
All
Latest
CellCarta and Pillar Biosciences Partner to Expand Tumor Profiling for Oncology Trials
The multi-year collaboration combines kitted next-generation sequencing panels with a global laboratory network to improve turnaround times and support diagnostic programs.
All
Latest
Insight Molecular Diagnostics Nears FDA Submission for Kidney Transplant Rejection Test Kit
Insight Molecular Diagnostics has completed clinical validation and received ISO 13485 certification for its GraftAssureDx kidney transplant rejection test kit, moving toward FDA submission, according to the company.
GRAIL Submits FDA Application for Multi-Cancer Early Detection Test
GRAIL has submitted an FDA premarket approval application for its Galleri multi-cancer early detection test, supported by data from more than 25,000 participants in US and UK clinical trials.
Read More
Blood Test Tracks Brain Injury Progression After Stroke
Researchers have identified brain-derived tau as a blood biomarker that tracks brain injury progression after ischemic stroke and predicts long-term outcomes, according to a study of over 1,200 patients published in Science Translational Medicine.
Read More
Labcorp Plans 500,000-Square-Foot Facility in Indiana to Expand Central Lab Services
Labcorp will build a 500,000-square-foot facility in Brownsburg, Indiana, expanding its Indianapolis-area lab capacity by 40% to support clinical trial operations.
Read More
UK Hospital Trials 60-Second Test for Winter Respiratory Infections
University Hospital Southampton is trialing a point-of-care biosensor test for flu, COVID-19, and RSV, delivering results in four minutes, according to the hospital.
Read More
FDA Approves Companion Diagnostic for Colorectal Cancer Treatment
The FDA has approved a companion diagnostic for identifying BRAF V600E-mutant metastatic colorectal cancer patients eligible for encorafenib combination therapy.
Read More
Finger Prick Blood Test for Alzheimer’s Diagnosis Enters Large-Scale Trial
A large-scale international trial is evaluating a finger prick blood test for Alzheimer’s, analyzing three protein biomarkers as a potential alternative to PET scans and lumbar punctures.
Read More
Tear-Based Diagnostic Test for Red Eye Conditions Enters Clinical Study
The test is being developed to differentiate between adenoviral conjunctivitis, herpetic keratitis, and allergic conjunctivitis at the point of care.
Read More
CTC Counts Show Value in Guiding Metastatic Breast Cancer Treatment Decisions
Researchers found that circulating tumor cell counts stratified patients by disease aggressiveness and were associated with differing outcomes following endocrine versus combination therapy.
Read More
Plasma pTau Shows Promise as Early Endpoint in Alzheimer’s Trials
New cross-trial analysis supports the biomarker’s potential to predict clinical benefit, reinforcing biomarker-driven trial designs.
Read More
Trial Highlights Biomarker and Clinical Predictors of Long-Term Concussion Symptoms
Findings show that early symptom patterns and biomarker data may help forecast which mild traumatic brain injury patients will experience 30-day symptom persistence.
Read More
Large Clinical Trial to Assess Nasal Swab Test for Guiding Lung Cancer Care
The 2,400-patient study evaluates the Percepta Nasal Swab test’s ability to guide management decisions for patients with lung nodules.
Read More
Clinical Study to Evaluate ctDNA Test for Guiding Lung Cancer Treatment
Haystack Oncology and Rutgers Cancer Institute collaborate on phase II trial examining minimal residual disease testing in stage II/III NSCLC patients.
Read More
Phase 2B COPD Trial to Use Point-of-Care Test for Rhinovirus Detection
The phase 2B trial of vapendavir will use bioMérieux’s Biofire Spotfire panel—a CLIA-waived molecular test that detects rhinovirus—to confirm infections in COPD patients.
Read More
Foresight Diagnostics Reports Clinical Performance Data for ctDNA Assay in Early-Stage Lung Cancer
Study shows Foresight CLARITY demonstrated 68% pre-operative and 38% post-operative MRD detection rates in stage I lung cancer patients.
Read More
AI Platform Aims to Streamline Clinical Trial Matching at Diagnosis
The new platform automatically identifies clinical trial candidates at diagnosis, leveraging network expected to process 8 million pathology cases annually.
Read More